This forum is for questions about medical issues and research aspects of
Hepatitis C such as, questions about being newly diagnosed, questions about current treatments, information and participation in discussions about research studies and clinical trials related to Hepatitis. If you would like to communicate with other people who have been touched by Hepatitis, please visit our new
Hepatitis Social/Living with Hepatitis forum
I think the trial that Ronnie Pat Webb is probably discussing is Medtronic’s COPE-HCV study. I believe they are testing an insulin-like pump using Intron-A (old non-Peg formula) against the current standard of care. It’ll be interesting to see if this offers any additional benefits.
http://wwwp.medtronic.com/Newsroom/NewsReleaseDetails.do?itemId=1251836481767&lang=en_US
http://clinicaltrials.gov/ct2/show/NCT00919633?term=medtronics+interferon&rank=1
RonniePatWebb;
Best of luck to you—
Bill
You can see from this chart that peg interferon level at 180mg is very consistent over 7 days, so I am not sure what they are hoping to achieve. Only the trial definition can explain it. I can only guess that they hope to minimize the trough, but you can see from the chart, there isn't much of a trough taking the shot every 7 days.
Brent